Healthcare at Home Ltd Appoints Nigel Brooksby and Graeme Duncan to Expand Pharmaceutical Services Business

BURTON UPON TRENT, England, April 7, 2011 /PRNewswire/ -- Healthcare at Home Ltd (http://www.hah.co.uk), Europe's leading provider of home healthcare and value-adding pharmaceutical services, announces that it has appointed Nigel Brooksby as a Senior Strategic Advisor and Graeme Duncan as Director of Strategy, for the Company's fast-growing pharmaceutical services business.

Nigel Brooksby has almost 40 years' experience in the life sciences industry. Most recently he held the position of Chairman and Managing Director of sanofi-aventis in the UK, where he was also a member of sanofi-aventis' European Executive Committee. From 2008 to 2010 Nigel held the position of President of the UK's Association of the British Pharmaceutical Industry and served as a member of the Confederation of British Industry's Presidents Committee. Nigel now holds several life sciences, academic, and government positions at a senior board level, including representing the life sciences industry on the Cogent Board and being Chair of the Cogent Life Sciences Skills Strategy Board. Nigel will work closely with the Senior Management Team at Healthcare at Home, advising on the formulation of both innovative services and strategic partnerships within the pharmaceutical sector.

Commenting on his appointment, Nigel Brooksby said: "I am delighted to be working with Healthcare at Home to support their service offering in the pharmaceutical sector. Healthcare at Home is already the leading home healthcare provider in Europe, but a significant growth opportunity still exists to transform the way in which healthcare services are provided for patients across the region. With the challenges facing the pharmaceutical industry, particularly around market access and supply chain management, Healthcare at Home is ideally placed to become a key partner for major pharmaceutical companies going forward."

Graeme Duncan, 37, has joined Healthcare at Home as Director of Strategy of the Company's pharmaceutical services business. Graeme was most recently the Chief Executive Officer of Caspian Learning, a software company operating within the simulation and learning sectors, where he remains a Non-Executive Director. Prior to joining Caspian, Graeme held the positions of Head of Marketing and Commercial Director of IVAX Pharmaceuticals UK. This role was preceded by a six-year career at GlaxoSmithKline and GlaxoWellcome where he held a variety of sales and marketing roles, the last of which was Marketing Manager for GlaxoSmithKline's flagship diabetes franchise. Graeme has also worked within the consulting sector and has led international partnering strategies for organizations alongside partners including Accenture and IBM. Graeme will assume responsibility for further developing the corporate strategy for Healthcare at Home within the pharmaceutical sector, including devising, developing and launching new innovative services and partnering arrangements with pharmaceutical companies.

Commenting on his appointment, Graeme Duncan said: "Healthcare at Home can provide a broad spectrum of services for pharmaceutical companies. These range from medicine administration and education programmes, through to high value bespoke patient adherence and market access initiatives. I am excited to be joining at a time when the pharmaceutical sector is seeking new and innovative services linked to both market access and product extension, and feel sure that Healthcare at Home can further strengthen its position as the partner of choice within this area."

Mike Gordon, Chief Executive of Healthcare at Home, said: "We are pleased to welcome Nigel and Graeme to Healthcare at Home. Both Nigel and Graeme bring broad experience that will be important in further developing our partnerships with global pharmaceutical companies and delivering continued innovation and growth in our service delivery."

Healthcare at Home provides a vast range of clinical services across many therapy areas to patients of almost every NHS trust in the UK, with expanding operations in Europe and beyond. A wealth of evidence demonstrates that its services can improve treatment outcomes and reduce treatment costs, whilst being highly valued by patients. Services are funded by the NHS in the UK, private medical insurers, and the majority of the top 30 pharmaceutical companies. Healthcare at Home's services can aid market access, development and product extension.

About Healthcare at Home Ltd

Healthcare at Home was established in 1992 by Charles Walsh, now Executive Chairman. The vision was, and remains today, to enhance the way in which clinical and pharmaceutical services are provided for patients, their families and carers. The vision is realised through the provision of innovative services to patients in the comfort of their own homes, within the community, and on site within the NHS and the independent sector.

The company has grown rapidly since its formation to become a leading provider of home healthcare internationally. With headquarters in Burton on Trent, Staffordshire, Healthcare at Home operates from locations throughout the UK, enabling its services to be provided to patients anywhere in the UK, from a local base. Total staff numbers within the company have risen to just over 1,000, of whom approximately half are highly skilled and experienced clinical staff. The Company has a strong and substantial financial track record and has a minimum risk score as rated by Dun & Bradstreet (D&B), the financial rating agency.

    For further information please contact:
    Healthcare at Home
    Steve Davis, Head of Marketing
    Tel:+44(0)7818-016160
    Email: [email protected]

    M:Communications
    Emma Thompson / Nick Francis
    Tel: +44(0)207-920-2330
    Email: [email protected]

SOURCE Healthcare at Home Ltd